7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

Quick Answer: The Needlestick Safety and Prevention Act (2000) amended the OSHA Bloodborne Pathogens Standard to require a Sharps Injury Log, annual Exposure Control Plan review documenting evaluation of safer devices, and frontline non-managerial employee input into device selection. Engineering controls come first. Latex Type I is immediate IgE hypersensitivity; Type IV is delayed contact dermatitis from chemical accelerators.

Section 7.1 covers what happens after an exposure. This section covers preventing it, and the related blueprint task of consulting with appropriate personnel on use of alternative infection prevention options, such as product allergies.

---

The Regulatory Requirements

The Needlestick Safety and Prevention Act of 2000 added three concrete obligations to 29 CFR 1910.1030:

1. The Sharps Injury Log

A log maintained in a manner that protects employee confidentiality, recording at minimum:

• The type and brand of device involved
• The department or work area where the incident occurred
• An explanation of how the incident occurred

This granularity is deliberate: it is what allows a facility to identify that one brand of winged steel needle causes a disproportionate share of injuries.

2. Annual Exposure Control Plan review

The plan must be reviewed and updated at least annually, and whenever new tasks or procedures affect exposure. The review must document consideration and implementation of appropriate, commercially available, effective safer devices. "We looked and there was nothing" is not sufficient once safer devices exist on the market.

3. Frontline employee input

Employers must solicit input from non-managerial employees responsible for direct patient care in identifying, evaluating, and selecting engineering and work practice controls, and must document that solicitation in the Exposure Control Plan. A safety device selected without the input of the people who will use it is routinely defeated in practice.

---

Controls, In Order of Effectiveness

graph TD
    A["1. ELIMINATION<br/>Remove the sharp entirely -<br/>needleless IV connectors, jet injectors,<br/>blunt suture needles, adhesive skin closure"] --> B["2. ENGINEERING CONTROLS<br/>Safety-engineered sharps with retracting,<br/>shielding or blunting mechanisms;<br/>sharps containers at point of use"]
    B --> C["3. WORK PRACTICE CONTROLS<br/>No recapping; neutral zone / hands-free<br/>passing in the OR; no hand-to-hand<br/>transfer of sharps; activate safety<br/>feature immediately"]
    C --> D["4. PPE<br/>Gloves, double gloving, eye protection -<br/>reduces inoculum but does not<br/>prevent puncture"]

Key work practice rules

• Do not recap. If recapping is unavoidable for a specific clinical reason, use a one-handed scoop technique or a mechanical recapping device — never a two-handed recap.
• Do not bend, shear, or break contaminated needles.
• Activate the safety mechanism immediately after use, before setting the device down.
• Neutral zone / hands-free technique in the operating room: sharps are placed in a designated basin or magnetic pad rather than passed hand to hand. This eliminates a substantial share of intraoperative injuries.
• Announce sharps passes verbally.
• Blunt suture needles for fascia and muscle closure substantially reduce suture-needle injuries and should be default where clinically appropriate.
• Double gloving in surgery reduces the volume of blood inoculated when a puncture occurs and detects perforations; it does not prevent the puncture.

---

Analyzing Sharps Injury Data

The log becomes prevention only when it is analyzed. Standard cuts:

Benchmarking uses injuries per 100 occupied beds or per 100 full-time equivalents, drawing on tools such as EPINet.

Exam Tip: Underreporting is the dominant data problem — a large fraction of injuries are never reported, with the highest underreporting among physicians and surgical staff. A falling injury rate may reflect falling reporting. Reporting culture, an easy reporting process, and 24-hour access to evaluation are prerequisites to trusting the data.

---

Product Sensitivities and Alternatives

Natural rubber latex

Risk factors for Type I sensitization include frequent glove use, spina bifida, multiple surgeries, and cross-reactive food allergies (banana, avocado, kiwi, chestnut). Powdered latex gloves were the major sensitization route because powder aerosolizes latex protein into ambient air; FDA banned powdered patient examination and surgeon's gloves effective January 2017. Nitrile gloves are the standard alternative and provide equivalent barrier protection.

Chemical sensitivities

The infection preventionist's consultation role

When a staff member cannot tolerate a standard product, the IP is asked to identify an alternative. The judgment must satisfy three tests simultaneously:

1. Is the alternative effective for the required task — the same EPA claims, the same barrier standard, the same contact time?
2. Is it compatible with the devices and surfaces involved?
3. Is it available reliably, and does the affected worker know how to obtain it?

Work with occupational health, which owns the medical evaluation, and document the accommodation. The Exposure Control Plan should name the alternatives available so a worker with a sensitivity is not left improvising at 3 a.m. Never solve a sensitivity by allowing the worker to omit the control entirely — a nurse who cannot tolerate one glove material needs a different glove, not fewer gloves.